MMP20 hemopexin domain mutation in amelogenesis imperfecta

Journal of Dental Research

Volumn 89, Issue 1, 2010, Pages 46-50

  Lee, S K ^a   Seymen, F ^b   Kang, H Y ^a   Lee, K E ^a   Gencay, K ^b   Tuna, B ^b   Kim, J W ^a,c  

^a School of Dentistry   (South Korea)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Seoul National University   (South Korea)

Author keywords

Amelogenesis imperfecta.; Enamel; Hemopexin; MMP20; Tooth

Indexed keywords

AMELOGENIN; AMELX PROTEIN, HUMAN; ENAMEL PROTEIN; HEMOPEXIN; KALLIKREIN; KALLIKREIN 4; MATRIX METALLOPROTEINASE 20;

ADULT; AMELOGENESIS IMPERFECTA; ARTICLE; CASE CONTROL STUDY; CASE REPORT; CHILD; ENAMEL; FEMALE; GENETICS; HAPLOTYPE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEDIGREE; POINT MUTATION; REFERENCE VALUE; TOOTH DISCOLORATION;

ADULT; AMELOGENESIS IMPERFECTA; AMELOGENIN; CASE-CONTROL STUDIES; CHILD; DENTAL ENAMEL; DENTAL ENAMEL PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; HAPLOTYPES; HEMOPEXIN; HUMANS; KALLIKREINS; MALE; MATRIX METALLOPROTEINASE 20; PEDIGREE; POINT MUTATION; REFERENCE VALUES; TOOTH DISCOLORATION;

EID: 72449203350     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034509352844     Document Type: Article

References (25)

1. Bartlett JD, Beniash E., Lee DH, Smith CE (2004). Decreased mineral content in MMP-20 null mouse enamel is prominent during the maturation stage. J Dent Res 83: 909-913.
2. Caterina JJ, Skobe Z., Shi J., Ding Y., Simmer JP, Birkedal-Hansen H., et al. (2002). Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem 277: 49598-49604.
3. Fukae M., Tanabe T., Uchida T., Lee SK, Ryu OH, Murakami C., et al. (1998). Enamelysin (matrix metalloproteinase-20): localization in the developing tooth and effects of pH and calcium on amelogenin hydrolysis. J Dent Res 77: 1580-1588.
4. Gomis-Ruth F. (2004). Hemopexin domains. In: Handbook of metalloproteins. Vol. 3. Messerschmidt A, Bode W, Cygler M, editors. Chichester: John Wiley & Sons, Ltd, pp. 631-646.
5. Hart PS, Hart TC, Michalec MD, Ryu OH, Simmons D., Hong S., et al. (2004). Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta. J Med Genet 41: 545-549.
6. Hart PS, Becerik S., Cogulu D., Emingil G., Ozdemir-Ozenen D., Han ST, et al. (2009). Novel FAM83H mutations in Turkish families with autosomal dominant hypocalcified amelogenesis imperfecta. Clin Genet 75: 401-404.
7. Iwata T., Yamakoshi Y., Hu JC, Ishikawa I., Bartlett JD, Krebsbach PH, et al. (2007). Processing of ameloblastin by MMP-20. J Dent Res 86: 153-157.
8. Kida M., Sakiyama Y., Matsuda A., Takabayashi S., Ochi H., Sekiguchi H., et al. (2007). A novel missense mutation (p.P52R) in amelogenin gene causing X-linked amelogenesis imperfecta. J Dent Res 86: 69-72.
9. Kim JW, Simmer JP, Hu YY, Lin BP-L, Boyd C., Wright JT, et al. (2004). Amelogenin p.M1T and p.W4S mutations underlying hypoplastic X-linked amelogenesis imperfecta. J Dent Res 83: 378-383.
10. Kim JW, Seymen F., Lin BP, Kiziltan B., Gencay K., Simmer JP, et al. (2005 a). ENAM mutations in autosomal-dominant amelogenesis imperfecta. J Dent Res 84: 278-282.
11. Kim JW, Simmer JP, Hart TC, Hart PS, Ramaswami MD, Bartlett JD, et al. (2005 b). MMP-20 mutation in autosomal recessive pigmented hypomaturation amelogenesis imperfecta. J Med Genet 42: 271-275.
12. Kim JW, Lee SK, Lee ZH, Park JC, Lee KE, Lee MH, et al. (2008). FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta. Am J Hum Genet 82: 489-494.
13. Lee SK, Hu JC, Bartlett JD, Lee KE, Lin BP, Simmer JP, et al. (2008). Mutational spectrum of FAM83H: the C-terminal portion is required for tooth enamel calcification. Hum Mutat 29: E95 - E99.
14. Libson AM, Gittis AG, Collier IE, Marmer BL, Goldberg GI, Lattman EE (1995). Crystal structure of the haemopexin-like C-terminal domain of gelatinase A. Nat Struct Biol 2: 938-942.
15. Overall CM, King AE, Bigg HF, McQuibban A., Atherstone J., Sam DK, et al. (1999). Identification of the TIMP-2 binding site on the gelatinase A hemopexin C-domain by site-directed mutagenesis and the yeast two-hybrid system. Ann NY Acad Sci 878: 747-753.
16. Ozdemir D., Hart PS, Ryu OH, Choi SJ, Ozdemir-Karatas M., Firatli E., et al. (2005 a). MMP20 active-site mutation in hypomaturation amelogenesis imperfecta. J Dent Res 84: 1031-1035.
17. Ozdemir D., Hart PS, Firatli E., Aren G., Ryu OH, Hart TC (2005 b). Phenotype of ENAM mutations is dosage-dependent. J Dent Res 84: 1036-1041.
18. Papagerakis P., Lin HK, Lee KY, Hu Y., Simmer JP, Bartlett JD, et al. (2008). Premature stop codon in MMP20 causing amelogenesis imperfecta. J Dent Res 87: 56-59.
19. Romisch K. (2005). Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol 21: 435-456.
20. Ryu OH, Fincham AG, Hu CC, Zhang C., Qian Q., Bartlett JD, et al. (1999). Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins. J Dent Res 78: 743-750.
21. Van den Steen PE, Van Aelst I., Hvidberg V., Piccard H., Fiten P., Jacobsen C., et al. (2006). The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. J Biol Chem 281: 18626-18637.
22. Wallon UM, Overall CM (1997). The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components. J Biol Chem 272: 7473-7481.
23. Witkop CJ Jr (1988). Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J Oral Pathol 17: 547-553.
24. Witkop CJ Jr, Sauk JJ Jr (1976). Heritable defects of enamel. In: Oral facial genetics. Stewart RE, Prescott GH, editors. St. Louis: C.V. Mosby Co., pp. 151-226.
25. Yamada Y., Yamakoshi Y., Gerlach RF, Hu JC-C, Matsumoto K., Fukae M., et al. (2003). Purification and characterization of enamelysin from secretory stage pig enamel. Arch Comp Biol Tooth Enam 8: 21-25.